The Up-Regulation of Oxidative Stress as a Potential Mechanism of Novel MAO-B Inhibitors for Glioblastoma Treatment by Guya Diletta Marconi, Marialucia Gallorini, Simone Carradori, Paolo Guglielmi, Amelia Cataldi, Susi Zara

Subjects: Get full text

Suitable Docking Protocol for the Design of Novel Coumarin Derivatives with Selective MAO-B Effects by Emilio Viktorov Mateev, Iva Valkova, Maya Georgieva, Alexander Zlatkov

Subjects: “…MAO-B inhibitors…”
Get full text

Synthesis and Biological Evaluation of <i>O</i>⁶-Aminoalkyl-Hispidol Analogs as Multifunctional Monoamine Oxidase-B Inhibitors towards Management of Neurodegenerative Di... by Ahmed H. E. Hassan, Hyeon Jeong Kim, Keontae Park, Yeonwoo Choi, Suyeon Moon, Chae Hyeon Lee, Yeon Ju Kim, Soo Bin Cho, Min Sung Gee, Danbi Lee, Jong-Hyun Park, Jong Kil Lee, Jong Hoon Ryu, Ki Duk Park, Yong Sup Lee

Subjects: Get full text

Pharmacological and Non-Pharmacological Treatments for Depression in Parkinson’s Disease: An Updated Review by Efthalia Angelopoulou, Evangelia Stanitsa, Claire Chrysanthi Karpodini, Anastasia Bougea, Dionysia Kontaxopoulou, Stella Fragkiadaki, Christos Koros, Vasiliki Epameinondas Georgakopoulou, George Fotakopoulos, Yiannis Koutedakis, Christina Piperi, Sokratis G. Papageorgiou

Subjects: Get full text

Antiparkinsonian activity of selective MAO-B inhibitors of different chemical structures by Vladimir N. Fedorov, Mikhail K. Korsakov, Anton A. Shetnev, Sergey S. Petukhov, Nikita N. Volkhin, Vladimir P. Vdovichenko, Anastasia A. Khokhlova, Salavat Sh. Suleymanov

Subjects: Get full text

Latest advances in dual inhibitors of acetylcholinesterase and monoamine oxidase B against Alzheimer’s disease by Dajiang Zou, Renzheng Liu, Yangjing Lv, Jianan Guo, Changjun Zhang, Yuanyuan Xie

Subjects: Get full text

Discovery of benzamide-hydroxypyridinone hybrids as potent multi-targeting agents for the treatment of Alzheimer's disease by Xiaoying Jiang, Jianan Guo, Changjun Zhang, Jinping Gu, Tao Zhou, Renren Bai, Yuanyuan Xie

Subjects: Get full text

Switching from Rasagiline to Safinamide as an Add-On Therapy Regimen in Patients with Levodopa: A Literature Review by Pilar Sanchez Alonso, Beatriz De La Casa-Fages, Araceli Alonso-Cánovas, Juan Carlos Martínez-Castrillo

Subjects: Get full text

Structure-Based Design of Novel MAO-B Inhibitors: A Review by Emilio Mateev, Maya Georgieva, Alexandrina Mateeva, Alexander Zlatkov, Shaban Ahmad, Khalid Raza, Vasco Azevedo, Debmalya Barh

Subjects: Get full text

Highly Potent, Selective, and Competitive Indole-Based MAO-B Inhibitors Protect PC12 Cells against 6-Hydroxydopamine- and Rotenone-Induced Oxidative Stress by Mohamed H. Elsherbeny, Jushin Kim, Noha A. Gouda, Lizaveta Gotina, Jungsook Cho, Ae Nim Pae, Kyeong Lee, Ki Duk Park, Ahmed Elkamhawy, Eun Joo Roh

Subjects: Get full text

Chalcones as Potential Ligands for the Treatment of Parkinson’s Disease by Ewelina Królicka, Katarzyna Kieć-Kononowicz, Dorota Łażewska

Subjects: Get full text

Practical aspects of prescribing antiparkinsonian drugs. The place of amantadines in the management of Parkinson’s disease by N. V. Titova, A. A. Portupeev

Subjects: Get full text

Discovery of MAO-B Inhibitor with Machine Learning, Topomer CoMFA, Molecular Docking and Multi-Spectroscopy Approaches by Linfeng Zheng, Xiangyang Qin, Jiao Wang, Mengying Zhang, Quanlin An, Jinzhi Xu, Xiaosheng Qu, Xin Cao, Bing Niu

Subjects: “…monoamine oxidase B (MAO-B) inhibitors…”
Get full text

Computational exploration of acefylline derivatives as MAO-B inhibitors for Parkinson’s disease: insights from molecular docking, DFT, ADMET, and molecular dynamics approaches by Ali Irfan, Ameer Fawad Zahoor, Yassir Boulaamane, Sadia Javed, Huma Hameed, Amal Maurady, Muhammed Tilahun Muhammed, Sajjad Ahmad, Sajjad Ahmad, Sajjad Ahmad, Aamal A. Al-Mutairi, Irum Shahzadi, Sami A. Al-Hussain, Magdi E. A. Zaki

Subjects: Get full text

Targeting MAO-B with Small-Molecule Inhibitors: A Decade of Advances in Anticancer Research (2012–2024) by Iyman Alsaad, Diana M. A. Abdel Rahman, Ola Al-Tamimi, Shayma’a A. Alhaj, Dima A. Sabbah, Rima Hajjo, Sanaa K. Bardaweel

Subjects: Get full text

Profile and frequency of antiparkinsonian drugs adverse reactions: a systematic review and meta-analysis by A. A. Tappakhov, T. E. Popova, A. I. Vasilev, T. G. Govorova, Yu. I. Khabarova, K. A. Timofeeva, N. A. Schnaider

Subjects: Get full text

Discovery of novel 2-(4-(benzyloxy)-5-(hydroxyl) phenyl) benzothiazole derivatives as multifunctional MAO-B inhibitors for the treatment of Parkinson’s disease by Zhongcheng Cao, Xingyue Wang, Tianlong Zhang, Xianwu Fu, Fan Zhang, Jiang Zhu

Subjects: Get full text

Synthesis, crystal structures, molecular docking and MAO-B inhibitory activity of transition metal complexes derived from 2-(4-(pyridin-2-yl)piperazin-1-yl)acetic acid by Yan-Jie Ren, Jin-Long Zhu, Li-Xin Zhang, Yin-Xiang Xu, Shao-Song Qian

Subjects: Get full text

Safinamide in the management of patients with Parkinson&rsquo;s disease not stabilized on levodopa: a review of the current clinical evidence by Bette S, Shpiner DS, Singer C, Moore H

Subjects: Get full text

Potential of Tryptamine Derivatives as Multi-Target Directed Ligands for Alzheimer’s Disease: AChE, MAO-B, and COX-2 as Molecular Targets by Saira Asghar, Nousheen Mushtaq, Ahsaan Ahmed, Laila Anwar, Rabya Munawar, Shamim Akhtar

Subjects: “…monoamine oxidase (MAO-B) inhibitors…”
Get full text